Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aurobindo Pharma, a developer of generic pharmaceuticals and active pharmaceutical ingredients, has received its first product approval from Swissmedic, Government of Switzerland for the license of finasteride APL tablets 5mg.
Subscribe to our email newsletter
According to Aurobindo Pharma, finasteride APL tablets 5mg is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostrate.